# Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery

> **NCT02012946** · PHASE4 · UNKNOWN · sponsor: **Azienda Policlinico Umberto I** · enrollment: 40 (estimated)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** Dobutamine

## Key facts

- **NCT ID:** NCT02012946
- **Lead sponsor:** Azienda Policlinico Umberto I
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2013-12
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02012946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02012946, "Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02012946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*